Description
ALKALOS
Description
Calcium citrate, magnesium, potassium bicarbonate and vitamin D3 supplement. Calcium and vitamin D3 contribute to bone health.
Ingredients
Unit A: Calcium Citrate, Vitamin D3 (cholecalciferol). Unit B: Magnesium Citrate, Potassium Citrate.
Nutritional characteristics
How to use
It is recommended to take 1 tablet A in the morning and 1 tablet B in the evening before going to bed.
Warnings
Do not exceed the recommended daily dose.
Keep out of reach of children under 3 years of age.
Supplements are not intended as a substitute for a varied diet.
Contraindicated in patients with hyperkalemia or hypermagnesemia, or conditions that may predispose to the appearance of such plasma alterations. These conditions include chronic renal failure, uncontrolled diabetes mellitus.
Concomitant administration of ALKALOS and potassium-sparing drugs (triamterene, spironolactone, amiloride) may cause hyperkalemia. It is therefore advisable to monitor the progress of potassium levels. No interactions with other drugs are known.
Rarely, mild gastrointestinal disturbances may develop during treatment, such as abdominal heaviness, nausea and occasionally diarrhoea.
The tablet form may be particularly suitable for these subjects.
Conservation
Best before date from production date, in intact packaging: 24 months.
Format
The package contains:
- 1 bottle of 60 tablets A
- 1 bottle of 60 tablets B.
Cod. 01016
Calcium citrate, magnesium, potassium bicarbonate and vitamin D3 supplement. Calcium and vitamin D3 contribute to bone health.
Ingredients
Unit A: Calcium Citrate, Vitamin D3 (cholecalciferol). Unit B: Magnesium Citrate, Potassium Citrate.
Nutritional characteristics
| Average values | for 1 tablet A | 1 tablet B |
| Calcium Citrate | 1,180 mg (equivalent to 250 mg of calcium) | - |
| Vitamin D3 | 7.5 mcg | - |
| Potassium Citrate | - | 715 mg (equivalent to 274 mg of potassium) |
| Magnesium Citrate | - | 263 mg (equivalent to 42.5 mg of magnesium) |
How to use
It is recommended to take 1 tablet A in the morning and 1 tablet B in the evening before going to bed.
Warnings
Do not exceed the recommended daily dose.
Keep out of reach of children under 3 years of age.
Supplements are not intended as a substitute for a varied diet.
Contraindicated in patients with hyperkalemia or hypermagnesemia, or conditions that may predispose to the appearance of such plasma alterations. These conditions include chronic renal failure, uncontrolled diabetes mellitus.
Concomitant administration of ALKALOS and potassium-sparing drugs (triamterene, spironolactone, amiloride) may cause hyperkalemia. It is therefore advisable to monitor the progress of potassium levels. No interactions with other drugs are known.
Rarely, mild gastrointestinal disturbances may develop during treatment, such as abdominal heaviness, nausea and occasionally diarrhoea.
The tablet form may be particularly suitable for these subjects.
Conservation
Best before date from production date, in intact packaging: 24 months.
Format
The package contains:
- 1 bottle of 60 tablets A
- 1 bottle of 60 tablets B.
Cod. 01016
